Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06775080 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
In this study, perioperative propranolol β-blockade was administered to patients with surgically resectable primary gastrointestinal tumors to explore the safety, efficacy, and alleviation of perioperative psychological stress. At the same time, a multi-omics study was conducted using clinical samples to explore the activation of anti-tumor immune response and its mechanism.
Trial Details
NCT Number NCT06775080
Lead Sponsor Huashan Hospital
Conditions
(from sponsor)		 Gastrointestinal Tumors
Related terms Digestive System Neoplasms
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov